期刊文献+

强直性脊柱炎全基因组扫描易感基因研究的Meta分析 被引量:1

Ankylosing spondylitis susceptibility loci defined by genome-search Meta-analysis
原文传递
导出
摘要 目的通过强直性脊柱炎(AS)全基因组扫描研究,进一步确定AS遗传易感基因的染色体区域定位。方法2007年12月于山东省立医院图书馆检索分析已发表的有关AS和血清阴性脊柱关节病(SpA)的全基因扫描文献结果,采用全基因组扫描研究的Meta分析(GSMA)软件进行分析。结果4项AS全基因组扫描研究共纳入479个家系1151例AS患者,GSMA结果显示5个区域最可能含有AS的易感位点,分别是6p22.3-p21.1、6pter-p22.3、17pter-p12、2p12-q22.1和5q34-qter。5项AS和SpA全基因组扫描研究共纳入544个家系1331例AS和SpA患者,GSMA结果发现6p22.3-p21和16q23.1-qter2个区域最可能含有AS的易感位点。结论GSMA显示6p22.3-p21.1是AS显著连锁区域,6pter-p22.3、17pter-p12、2p12-q22.1、5q34-qter和16q23.1-qter是AS的连锁区域。 Objective To investigate whether there is any consistent evidence of linkage across multiple studies,and to identify novel AS susceptibility loci by using GSMA method. Methods Genome-search Meta-analysis (GSMA) method was applied to genome scans of AS and spondyloarthropathy(SpA) to assess evidence for linkage across studies. Results Four AS genome scans including 479 families with 1151 affected individuals were used. Suggesting these BINS most likely contain AS-linked loci;BINS 6p22. 3 -p21.1,6pter- p22. 3,17pter- p12,2p12 -q22. 1 and 5q34 -qter. Four AS genome scans and one SpA scan including 544 families with 1,331 affected individuals were used. The GSMA produced genomewide evidence for linkage on bin 6p22. 3 - p21 and 16q23. 1 - qter. Conclusion This GSMA added the evidence of the HLA loci as the greatest susceptibility factor to AS and shows evidences of chromosome 6,17p,2,5q and 16q as non-HLA susceptibility loci.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2008年第12期1031-1033,共3页 Chinese Journal of Practical Internal Medicine
基金 山东省自然科学基金项目(Q2007c09) 山东省卫生厅资助基金(2007az014)
关键词 脊柱炎 强直性 全基因组扫描 META分析 spondylitis, ankylosing genome scan Meta analysis
  • 相关文献

参考文献11

  • 1Brown MA, Pile KD, Kennedy LG, et al. A genome-wide screen for susceptibility loci in ankylosing spondylitis [ J ]. Arthritis Rheum, 1998,41:588 -595.
  • 2Laval SH, Timms A, Edwards, et al. Whole-genome screening in ankylosing spondylitis:evidence of non-MHC genetic-susceptibility loci [ J ]. Am J Hum Genet, 2001,68 : 918 - 926.
  • 3Zhang G, Luo J, Bruckel J, et al. Genetic studies in familial ankylosing spondylitis susceptibility [ J ]. Arthritis Rheum, 2004,50 : 2246 - 2254.
  • 4顾鸣敏,袁文涛,杨珏琴,张静,熊晓燕,姚芳娟,陆振虞,王铸钢,黄薇,范丽安.全基因组扫描寻找强直性脊柱炎的易感基因位点[J].Acta Genetica Sinica,2004,31(3):217-220. 被引量:19
  • 5Miceli-Richard C, Zoualil H, Said-Nahal R, et al. Significant linkage to spondyloarthropathy on 9q31 -34 [ J]. Hum Mol Genet, 2004,13 : 1641 - 1648.
  • 6Levinson DF, Levinson MD, Segurado R, et al. Genome scan Metaanalysis of schizophrenia and bipolar disorder, Part Ⅰ: methods and power analysis[ J]. Am J Human Genet,2003 ,73 :17 -33.
  • 7Carter KW, Pluzhnikov A, Timms A E, et al. Combined analysis of three whole genome linkage scans for ankylosing spondylitis [ J ]. Rheumatology, 2007,46:763 - 771.
  • 8Lee YH, Rho YH, Choi S J, et al. Ankylosing spondylitis susceptibility loci defined by genome-search meta-analysis [ J ]. J Hum Genet ,2005,50:453 - 459.
  • 9McGarry F, Neilly J, Anderson N, et al. A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis [ J ]. Rheumatology ( Oxford ) , 2001,40 : 1359 - 364.
  • 10van der Paardt M, Cmsius JB, Garcla-Gonzalez MA, et al. Interleukin-lbeta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis [ J ]. Rheumatology ( Oxford ), 2002,41 : 1419 - 1423.

二级参考文献8

  • 1Mau W, Zeidler H, Mau R. Clinical features and prognosis of patients with possible ankylosing spondylitis: Results of a 10-year followup. J Rheumatol, 1998,15(5) : 1109 - 1114.
  • 2Brown M A, Kennedy L G, MacGregor A J, Darke C, Duncan E, Shatford J L, Taylor A, Calin A, Wordsworth P. Susceptibility to ankylosing spondylitis in twins : The role of genes, HLA, and the environment. Arthritis Rheum, 1997,40(10) : 1823 - 1828.
  • 3Brown M A, Pile K D, Kennedy L G, Campbell D, Andrew L, March R, Shatfort J L, Weeks D E, Calin A, Wordsworth P. A Genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum, 1998,41 (4) :588 - 595.
  • 4Laval S H, Timms A, Edwards S, Bradbury L, Brophy S, Milicic A,Rubin L, Siminovitch K A, Weeks D E, Calin A, Wordsworth B P, Browm M A. Whole-genome screening in ankylosing spondylitis:evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet,2001,68(4) :918 - 926.
  • 5van der Linden S, Valkenburg H, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis : A proposal for modification of the New York criteria. Arthritis Rheum, 1984,27(3) : 361 - 368.
  • 6Lathrop G M, Lalouel J M, White R L. Construction of human linkage maps: Likelihood calculations for multilocus linkage analysis. Genet Epidemiol, 1986,3( 1 ) : 39 - 52.
  • 7Kruglyak L, Daly M J, Reeve-Daly M P, Lander E S. Parametric and Nonparametric linkage analysis : A unified multipoint approach. Am J Hum Genet, 1996,58(6):1347- 1363.
  • 8庄启南,张静,熊晓燕,赵彦,徐世杰,黄薇.应用毛细管电泳技术进行高效、准确的微卫星位点自动基因组扫描[J].中华医学遗传学杂志,2002,19(3):253-256. 被引量:17

共引文献18

同被引文献12

  • 1梁柳琴,杨岫岩.强直性脊柱炎的临床诊治进展[J].新医学,2005,36(3):179-181. 被引量:28
  • 2FORSETH K O, HAFSTROM I, HUSBY G, et al. Comprehensive rehabilitation of patients with rheumatic diseases in a warm climate: a literature review [J]. J Rehabil Med, 2010, 42 (10): 897-902.
  • 3VAN DER LINDEN S, VALKENBURG H A, CATS A. Evaluation of diagnostic criteria for ankylosing spondylitis, a proposal for modification of the New York criteria[J]. Arthritis Rheum, 1984, 27 (4): 361-368.
  • 4TAM L S, GU J, YU D. Pathogenesis of ankylosing spondylitis[J]. Nat Rev Rheumatol, 2010, 6 (7): 399-405.
  • 5BRAUN J, SIEPER J. Spondyloarthritides[J]. Z Rheumatol, 2010, 69 (5): 425-432.
  • 6JANGJH, WARD M M, RUCKER A N, et al. Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients[J]. Radiology, 2011, 258 (1) : 192-198.
  • 7CHENH A, CHEN C H, LIAO H T, et al. Factors associated with radiographic spinal involvement and hip involvement in ankylosing spondylitis [ J ]. Semin Arthritis Rheum, 2010, Sep 25. [ Epub ahead of print] .
  • 8TOUSSIROT E. Late-onset ankylosing spondylitis and spondylarthritis: an update on clinical manifestations, differential diagnosis and pharmacological therapies [ J ]. Drugs Aging, 2010, 27 (7): 523-531.
  • 9CRUZAT V, CUCHACOVICH R, ESPINOZA L R. Undifferentiated spondyloarthritis: recent clinical and therapeutic advances[J]. CUlT Rheumatol Rep, 2010, 12 (5): 311-317.
  • 10HAIBEL H, SIEPER J. Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker? [ J ] . Curr Opin Rheum, 2010, 22 (4): 388-392.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部